Stocks of Bio-Techne Corp (NASDAQ:TECH) traded higher last session on Wall Street, up 0.14% to $48.40.
TECH stock price is now -6.44% away from the 50-day moving average and -27.76% away from the 200-day moving average. The market capitalization of the company currently stands at $7.59B.
With the price target of $59, Wells Fargo recently initiated with Overweight rating for Bio-Techne Corp (NASDAQ: TECH). , while ‘Evercore ISI’ rates the stock as ‘Outperform’
In other news, Herr Amy E., Director sold 1,860 shares of the company’s stock on Feb 14 ’25. The stock was sold for $122,691 at an average price of $65.96. Upon completion of the transaction, the Director now directly owns 1,976 shares in the company, valued at $95638.4. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 14 ’25, Domestic Partner of Director JOSHUA MOLHO bought 1,860 shares of the business’s stock. A total of $122,691 was incurred on buying the stock at an average price of $65.96. A total of 1.13% of the company’s stock is owned by insiders.
During the past 12 months, Bio-Techne Corp has had a low of $46.01 and a high of $83.62. As of last week, the company has a debt-to-equity ratio of 0.21, a current ratio of 3.71, and a quick ratio of 2.58.
The net profit margin was 10.89% and return on equity was 6.53% for TECH. The company reported revenue of $316.18 million for the quarter, compared to $303.43 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.2 percent. For the current quarter, analysts expect TECH to generate $315.41M in revenue.
